Jocelyn Bautista, MD

Appointed
2001

Education & Fellowships

Fellowship - Cleveland Clinic
Clinical Neurophysiology (Neurology)
Cleveland, OH United States
2001

Residency - Yale-New Haven Hospital
Neurology
New Haven, CT
1999

Internship - Yale-New Haven Hospital
Internal Medicine
New Haven, CT
1996

Medical Education - Washington University School of Medicine
St. Louis, MO
1995

Undergraduate - University of Illinois Hospital at Urbana-Champaign
Chemistry
Urbana, IL
1991

Professional Highlights

• American Academy of Neurology Clinical Research Training Fellowship Award, 2001
• Her work led to the identification a gene responsible for a familial syndrome of generalized epilepsy and paroxysmal dyskinesia
• National Institutes of Health grant to pursue further training and research in the complex genetics of human epilepsies, 2005
• Cleveland Clinic Innovator Award, 2005
• Presented “Gene Mapping in Complex Epilepsies” at the NIH-Sponsored Curing Epilepsy 2007 Junior Investigator Symposium
• Served as NIH/NINDS Epilepsy Benchmark Steward, 2007 to 2013
• Served on AAN/AES Antiepileptic Drug Guidelines Committee, 2008 to 2018
• Served on National Quality Forum Neurology Standing Committee, 2012-2013, 2016 to 2020

Certifications

• Psychiatry and Neurology - Clinical Neurophysiology
• Psychiatry and Neurology - Epilepsy
• Psychiatry and Neurology - Neurology

Specialty Interests

adult and geriatric epilepsy, adult epilepsy, clinical drug trials, clinical neurophysiology, EEG, Epilepsy, genetics, genetics of epilepsy, invasive EEG monitoring for pre-surgical evaluations, Seizure disorder treatment and surgery in brain malformations, seizure manifestations, vagus nerve stimulation, Video EEG

Memberships

• American Academy of Neurology
• American Epilepsy Society

See publications for Jocelyn Bautista, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 7/31/2024, Dr. Bautista has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.